The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
Clinical guideline published by European Alliance of Associations for Rheumatology (EULAR) on
The European Alliance of Associations for Rheumatology (EULAR) is a leading organization dedicated to advancing rheumatology through research, education, and advocacy. It develops clinical guidelines and recommendations to improve patient care and promotes collaboration among healthcare professionals across Europe.